KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) EPS (Weighted Average and Diluted) (2016 - 2026)

Medtronic's EPS (Weighted Average and Diluted) history spans 13 years, with the latest figure at $0.89 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) fell 11.88% year-over-year to $0.89; the TTM value through Jan 2026 reached $3.57, up 8.18%, while the annual FY2025 figure was $3.61, 30.8% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.89 at Medtronic, down from $1.06 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.1 in Q1 2022 and bottomed at $0.32 in Q4 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is $0.88 (2023), against an average of $0.83.
  • The largest annual shift saw EPS (Weighted Average and Diluted) plummeted 67.01% in 2022 before it soared 112.5% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.32 in 2022, then surged by 112.5% to $0.68 in 2023, then soared by 45.59% to $0.99 in 2024, then increased by 7.07% to $1.06 in 2025, then fell by 16.04% to $0.89 in 2026.
  • Per Business Quant, the three most recent readings for MDT's EPS (Weighted Average and Diluted) are $0.89 (Q1 2026), $1.06 (Q4 2025), and $0.81 (Q3 2025).